- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 31.9948 ↑ 0.36%
[as on 2 November, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth and its peers as on 2 November, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | -14.26% | 4.15% | -2.5% | 5.4% | 65.31% | 18.13% | -8.24% | 37.51% | 40.42% | -5.37% |
Discrete returns (monthly)
| Month | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 |
|---|
| Returns | -5.72% | 4.8% | -6.41% | 6.81% | 3.13% | 4.41% | 4.28% | 0.53% | -3.78% | -0.52% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | 12.21% | 1.32% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.49% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.51% |
Equity
Debt
| Name | Isin | Rating | Weight % | Yield |
|---|
Portfolio data is as on date 31 August, 2026
NAV history
Tata India Pharma & Healthcare Fund-Regular Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 2 November, 2026 | 31.9948 | 0.36% |
| 30 October, 2026 | 31.8801 | 0.6% |
| 29 October, 2026 | 31.6903 | 0.47% |
| 28 October, 2026 | 31.5426 | 1.22% |
| 27 October, 2026 | 31.1636 | 1.86% |
| 26 October, 2026 | 30.5938 | 1.35% |
| 23 October, 2026 | 30.1860 | -0.88% |
| 22 October, 2026 | 30.4546 | -0.29% |
| 21 October, 2026 | 30.5440 | -1.23% |
| 19 October, 2026 | 30.9230 | -1.02% |
| 16 October, 2026 | 31.2426 | 0.06% |
| 15 October, 2026 | 31.2250 | -0.19% |
| 14 October, 2026 | 31.2839 | -0.37% |
| 13 October, 2026 | 31.3993 | 0.14% |
| 12 October, 2026 | 31.3551 | 0.16% |
| 9 October, 2026 | 31.3050 | 0.34% |
| 8 October, 2026 | 31.1988 | -2.39% |
| 7 October, 2026 | 31.9621 | -0.43% |
| 6 October, 2026 | 32.1000 | 0.83% |
| 5 October, 2026 | 31.8344 | -1.02% |
| 1 October, 2026 | 32.1622 | -0.64% |
| 30 September, 2026 | 32.3705 | -2.03% |
| 29 September, 2026 | 33.0422 | 0.37% |
| 28 September, 2026 | 32.9202 | -0.8% |
| 25 September, 2026 | 33.1867 | -0.52% |
| 24 September, 2026 | 33.3598 | -0.56% |
| 23 September, 2026 | 33.5462 | 0.37% |
| 22 September, 2026 | 33.4220 | -0.31% |
| 21 September, 2026 | 33.5261 | 0.38% |
| 18 September, 2026 | 33.3996 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Regular Plan-Growth is 31.9948 as on 2 November, 2026.
What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 6.06% as on 2 November, 2026.
What are 1 year returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 4.15% as on 2 November, 2026.
What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 17.33% as on 2 November, 2026.
What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 13.02% as on 2 November, 2026.
What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 13.02% as on 2 November, 2026.
What are top 10 holdings of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
Top 10 holdings of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are:
- SUN PHARMACEUTICAL INDUSTRIES LTD
- HEALTHCARE GLOBAL ENTERPRISES LTD
- DIVI LABORATORIES LTD
- ABBOTT INDIA LTD
- RAINBOW CHILDRENS MEDICARE LTD
- APOLLO HOSPITALS ENTERPRISE LTD
- CIPLA LTD
- DR REDDYS LABORATORIES LTD
- MAX HEALTHCARE INSTITUTE LTD
- FORTIS HEALTHCARE LTD
- LUPIN LTD
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
Tata India Pharma & Healthcare Fund-Regular Plan-Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
| Holding period | Tax rate |
|---|
| Less than 1 year (STCG) | 20% |
| More than 1 year (LTCG) | Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount. |